Cumberland Pharmaceuticals CPIX Other Financing
Other Financing at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's other financing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's other financing?
- Cumberland Pharmaceuticals (CPIX) reported other financing of $702.3K in Q1 2026.
- How has Cumberland Pharmaceuticals's other financing changed year-over-year?
- Cumberland Pharmaceuticals's other financing increased by 37.4% year-over-year, from $511.13K to $702.3K.
- What is the long-term trend for Cumberland Pharmaceuticals's other financing?
- Over 4 years (2021 to 2025), Cumberland Pharmaceuticals's other financing has grown at a -5.7% compound annual growth rate (CAGR), from $2.17M to $1.71M.
- What does other financing mean?
- Miscellaneous financing cash flows not classified in specific line items.